Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
IGlarLixi
MDI - Multiple dose insulin injection
Locations
1
Czechia
Institute for Clinical and Experimental Medicine
Prague, Czechia
Start Date
July 1, 2021
Primary Completion Date
January 1, 2023
Completion Date
June 1, 2023
Last Updated
July 22, 2021
NCT06579404
NCT06311019
NCT05785832
NCT06268808
NCT05893797
NCT04585191
Lead Sponsor
Institute for Clinical and Experimental Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions